BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 27, 2014
View Archived Issues
UCP2 -866G/A polymorphism and genotypes as prognostic markers for ischemic stroke
Read More
Novel dual histamine H1/H4 antagonists presented for allergic conjunctivitis
Read More
New company Nurix launched with focus on the ubiquitin proteasome system
Read More
BioRestorative Therapies signs research agreement with Pfizer
Read More
IXICO gains additional Huntington's disease trial contracts
Read More
Novel TNF-alpha-expressing oncolytic adenovirus demonstrates antitumor activity
Read More
Pharmaxis' LOXL2 inhibitors show promise for fibrosis
Read More
U.S. researchers prepare novel nucleosides and prodrugs
Read More
CHMP adopts positive opinion for Plegridy as a treatment for multiple sclerosis
Read More
Retriacyl obtains FDA orphan drug status for RP
Read More
Salk's Glenn Center for Aging Research receives USD 3 million gift
Read More
Viking Therapeutics licenses five programs from Ligand Pharmaceuticals
Read More
Daiichi Sankyo receives additional indication approval in Japan for Ranmark
Read More
European researchers disclose new anti-S100-A4 MAbs
Read More
Shionogi patents novel AMPK activators for diabetes
Read More
Boehringer Ingelheim patent reports new CMV inhibitors
Read More
New E-selectin inhibitors designed by GlycoMimetics
Read More
FDA approves EkoSonic endovascular system
Read More
EMA committee makes Halaven recommendation
Read More
EMA's CHMP recommends approval of Simbrinza to reduce IOP
Read More
EMA committee hands down positive opinion on Arzerra for CLL
Read More
EMA recommends approval of Nuwiq for children and adults with hemophilia A
Read More
Elixir Medical presents results on CE Mark-approved novolimus-eluting coronary intervention systems
Read More
Pfizer rules out new offer for AstraZeneca
Read More
Taliglucerase alfa approved in Australia for Gaucher's disease
Read More
EMA's CHMP confirms negative opinion for RLX-030
Read More